Table 2. Clinicopathological variables and BDNF/TrkB expression in 150 gastric cancer patients.
|
TrkB expression
|
BDNF/TrkB axis
|
||||||
|---|---|---|---|---|---|---|---|
| Variable | n | High (n=64) | Low (n=86) | P | Co-expression (n=35) | Others (n=115) | P |
|
Gender
| |||||||
| Male | 119 | 54 | 65 | 188b | 29 | 90 | 0.557b |
| Female | 31 | 10 | 21 | 6 | 25 | ||
|
Age (y)
| |||||||
| <69 (median) | 71 | 30 | 41 | 0.923b | 12 | 59 | 0.078b |
| ⩾69 | 79 | 34 | 45 | 23 | 56 | ||
|
Tumour size
| |||||||
| ⩾5.5 cm (median) | 76 | 34 | 42 | 0.603b | 20 | 56 | 0.382b |
| <5.5 cm | 74 | 30 | 44 | 15 | 59 | ||
|
Histological type
| |||||||
| Intestinal type | 75 | 39 | 36 | 0.021a,b | 24 | 51 | 0.012a,b |
| Diffuse type | 75 | 25 | 50 | 11 | 64 | ||
|
Pathological T category
| |||||||
| pT1/2 | 52 | 18 | 34 | 0.146b | 9 | 43 | 0.204b |
| pT3/4 | 98 | 46 | 52 | 26 | 72 | ||
|
Venous invasion
| |||||||
| + | 119 | 51 | 68 | 0.926b | 30 | 89 | 0.287b |
| − | 31 | 13 | 18 | 5 | 26 | ||
|
Lymphatic invasion
| |||||||
| + | 138 | 61 | 77 | 0.197b | 33 | 105 | 0.569b |
| − | 12 | 3 | 9 | 2 | 10 | ||
|
Lymph node metastasis
| |||||||
| N0 | 45 | 14 | 31 | 0.061b | 5 | 40 | 0.021a,b |
| N1 | 105 | 50 | 55 | 30 | 75 | ||
|
Liver metastasis
| |||||||
| H0 | 138 | 58 | 80 | 0.592b | 33 | 105 | 0.569b |
| H1 | 12 | 6 | 6 | 2 | 10 | ||
|
Peritoneal carcinomatosis
| |||||||
| P0 | 123 | 50 | 73 | 0.287b | 27 | 96 | 0.393b |
| P1 | 27 | 14 | 13 | 8 | 19 | ||
|
Stage classification
| |||||||
| Stage I–II | 48 | 17 | 31 | 0.218b | 8 | 40 | 0.185b |
| Stage III–IV | 102 | 47 | 55 | 27 | 75 | ||
P<0.05.
Pearson’s χ2-test.